Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis

Abstract Background Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint destruction and systemic inflammation, both of which significantly impair patients’ quality of life. Mild cognitive impairment (MCI), a reversible precursor to dementia, is increasingly prevalent am...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Yan, Hua Guo, Lin-Xin Zhang, Pei Chen, Yong-Ku Du, Juan Li, Ya-Ya Gao, Nan Ye
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Rheumatology
Subjects:
Online Access:https://doi.org/10.1186/s41927-025-00538-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849389186280325120
author Jun Yan
Hua Guo
Lin-Xin Zhang
Pei Chen
Yong-Ku Du
Juan Li
Ya-Ya Gao
Nan Ye
author_facet Jun Yan
Hua Guo
Lin-Xin Zhang
Pei Chen
Yong-Ku Du
Juan Li
Ya-Ya Gao
Nan Ye
author_sort Jun Yan
collection DOAJ
description Abstract Background Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint destruction and systemic inflammation, both of which significantly impair patients’ quality of life. Mild cognitive impairment (MCI), a reversible precursor to dementia, is increasingly prevalent among elderly RA patients. Early identification of MCI in this population allows for timely interventions to slow cognitive decline. Objective This study aims to identify independent risk factors for MCI in elderly patients with RA and to develop a predictive nomogram. Methods We enrolled 378 elderly RA patients, aged 60 to 80 years, from Xi’an Fifth Hospital between December 2023 and December 2024. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), with scores ranging from 20 to 26 indicating MCI. We analyzed demographic, clinical, and laboratory data to identify risk factors through logistic regression and constructed a nomogram. The model’s performance was evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Results Among the 378 patients, 94 (24.87%) were classified in the RA-MCI group. Multivariate analysis identified the course of disease (COD) (OR = 1.07, 95% CI: 1.03–1.10), elevated Disease Activity Score-28 (DAS28) (OR = 1.31, 95% CI: 1.13–1.53), high C-reactive protein (CRP) levels (OR = 1.01, 95% CI: 1.01–1.02), and osteoporosis (OP) (OR = 1.88, 95% CI: 1.14–3.13) as independent risk factors. The nomogram demonstrated moderate discrimination (AUC = 0.750, 95% CI: 0.696–0.805) and clinical utility. Conclusion The COD, OP, DAS28, and CRP levels are key predictors of MCI in elderly RA patients. The proposed nomogram provides a practical tool for early risk stratification, facilitating targeted interventions to delay cognitive decline. Trial registration This study conformed to the principles outlined in the Declaration of Helsinki and received approval from the Medical Ethics Committee of Xi’an Fifth Hospital (Approval No.: [2023] Ethics Review 55). Additionally, the trial was registered with the Chinese Clinical Trial Registry (Registration No.: ChiCTR2300077337, Registration Date: 2023-11-01). Written informed consent was obtained from all individual participants included in the study.
format Article
id doaj-art-3b40887e31584241b1f55652c662673f
institution Kabale University
issn 2520-1026
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Rheumatology
spelling doaj-art-3b40887e31584241b1f55652c662673f2025-08-20T03:42:02ZengBMCBMC Rheumatology2520-10262025-07-019111010.1186/s41927-025-00538-3Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritisJun Yan0Hua Guo1Lin-Xin Zhang2Pei Chen3Yong-Ku Du4Juan Li5Ya-Ya Gao6Nan Ye7Department of Neurology, Xi’an Fifth HospitalDepartment of Neurology, Xi’an Fifth HospitalDepartment of Neurology, Xi’an Fifth HospitalDepartment of Neurology, Xi’an Fifth HospitalDepartment of Radiology, Xi’an Fifth HospitalDepartment of Rheumatology, Xi’an Fifth HospitalDepartment of Neurology, Xi’an Fifth HospitalDepartment of Neurology, Xi’an Fifth HospitalAbstract Background Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint destruction and systemic inflammation, both of which significantly impair patients’ quality of life. Mild cognitive impairment (MCI), a reversible precursor to dementia, is increasingly prevalent among elderly RA patients. Early identification of MCI in this population allows for timely interventions to slow cognitive decline. Objective This study aims to identify independent risk factors for MCI in elderly patients with RA and to develop a predictive nomogram. Methods We enrolled 378 elderly RA patients, aged 60 to 80 years, from Xi’an Fifth Hospital between December 2023 and December 2024. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), with scores ranging from 20 to 26 indicating MCI. We analyzed demographic, clinical, and laboratory data to identify risk factors through logistic regression and constructed a nomogram. The model’s performance was evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Results Among the 378 patients, 94 (24.87%) were classified in the RA-MCI group. Multivariate analysis identified the course of disease (COD) (OR = 1.07, 95% CI: 1.03–1.10), elevated Disease Activity Score-28 (DAS28) (OR = 1.31, 95% CI: 1.13–1.53), high C-reactive protein (CRP) levels (OR = 1.01, 95% CI: 1.01–1.02), and osteoporosis (OP) (OR = 1.88, 95% CI: 1.14–3.13) as independent risk factors. The nomogram demonstrated moderate discrimination (AUC = 0.750, 95% CI: 0.696–0.805) and clinical utility. Conclusion The COD, OP, DAS28, and CRP levels are key predictors of MCI in elderly RA patients. The proposed nomogram provides a practical tool for early risk stratification, facilitating targeted interventions to delay cognitive decline. Trial registration This study conformed to the principles outlined in the Declaration of Helsinki and received approval from the Medical Ethics Committee of Xi’an Fifth Hospital (Approval No.: [2023] Ethics Review 55). Additionally, the trial was registered with the Chinese Clinical Trial Registry (Registration No.: ChiCTR2300077337, Registration Date: 2023-11-01). Written informed consent was obtained from all individual participants included in the study.https://doi.org/10.1186/s41927-025-00538-3AgingRheumatoid arthritisMild cognitive impairmentPredictive model
spellingShingle Jun Yan
Hua Guo
Lin-Xin Zhang
Pei Chen
Yong-Ku Du
Juan Li
Ya-Ya Gao
Nan Ye
Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis
BMC Rheumatology
Aging
Rheumatoid arthritis
Mild cognitive impairment
Predictive model
title Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis
title_full Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis
title_fullStr Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis
title_full_unstemmed Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis
title_short Risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis
title_sort risk factors and predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis
topic Aging
Rheumatoid arthritis
Mild cognitive impairment
Predictive model
url https://doi.org/10.1186/s41927-025-00538-3
work_keys_str_mv AT junyan riskfactorsandpredictivemodelformildcognitiveimpairmentinelderlypatientswithrheumatoidarthritis
AT huaguo riskfactorsandpredictivemodelformildcognitiveimpairmentinelderlypatientswithrheumatoidarthritis
AT linxinzhang riskfactorsandpredictivemodelformildcognitiveimpairmentinelderlypatientswithrheumatoidarthritis
AT peichen riskfactorsandpredictivemodelformildcognitiveimpairmentinelderlypatientswithrheumatoidarthritis
AT yongkudu riskfactorsandpredictivemodelformildcognitiveimpairmentinelderlypatientswithrheumatoidarthritis
AT juanli riskfactorsandpredictivemodelformildcognitiveimpairmentinelderlypatientswithrheumatoidarthritis
AT yayagao riskfactorsandpredictivemodelformildcognitiveimpairmentinelderlypatientswithrheumatoidarthritis
AT nanye riskfactorsandpredictivemodelformildcognitiveimpairmentinelderlypatientswithrheumatoidarthritis